טוען...
1q21扩增对硼替佐米治疗初治多发性骨髓瘤患者疗效和预后的影响
OBJECTIVE: To investigate the effect of 1q21 amplification (1q) on the therapeutic response and prognosis of bortezomib(Btz) in the treatment of newly diagnosed multiple myeloma (MM) patients. METHODS: A total of 180 newly diagnosed MM were included for analyses of clinical characteristics, cytogene...
שמור ב:
| הוצא לאור ב: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Editorial office of Chinese Journal of Hematology
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342892/ https://ncbi.nlm.nih.gov/pubmed/29779352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.05.013 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|